The field of diabetes treatment continues to experience a surge in innovation with the emergence of novel GLP-1 receptor agonists. Among these, retatrutide and trizepatide have gained prominence as potential https://adamtwcq258915.atualblog.com/45575066/new-glp-1-receptor-agonists-retatrutide-and-trizepatide